Cargando…

From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer

SIMPLE SUMMARY: Medullary thyroid cancer derives from calcitonin-producing C cells and is characterized by sporadic and familial RET-mutated forms. Serum calcitonin represents the most reliable and sensitive marker for diagnosis and postsurgical monitoring of medullary thyroid cancer. However, in so...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ricci, Claudia, Salvemini, Antonia, Dalmiglio, Cristina, Castagna, Maria Grazia, Cantara, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417429/ https://www.ncbi.nlm.nih.gov/pubmed/37568824 http://dx.doi.org/10.3390/cancers15154009

Ejemplares similares

Editorial: Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Clinical and Genetic Update
por: Valerio, Laura, et al.
Publicado: (2022)

Familial non-medullary thyroid cancer: a critical review
por: Capezzone, M., et al.
Publicado: (2020)

Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer
por: Cantara, Silvia, et al.
Publicado: (2023)

Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients
por: Capezzone, Marco, et al.
Publicado: (2022)

CONUT Score: A New Tool for Predicting Prognosis in Patients with Advanced Thyroid Cancer Treated with TKI
por: Dalmiglio, Cristina, et al.
Publicado: (2022)

Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value
por: Citarella, Anna, et al.
Publicado: (2023)

PAPPA Expression in Indeterminate Thyroid Nodules as Screening Test to Select Patients for Molecular Testing
por: Marzocchi, Carlotta, et al.
Publicado: (2022)

Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis
por: Cantara, Silvia, et al.
Publicado: (2017)

Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer
por: Valerio, Laura, et al.
Publicado: (2023)

miRNA Targets: From Prediction Tools to Experimental Validation
por: Riolo, Giulia, et al.
Publicado: (2020)

Diagnosis of medullary thyroid cancer
por: Marchisotta, Stefania, et al.
Publicado: (2009)

Thyroid Collision Tumors: The Presence of the Medullary Thyroid Carcinoma Component Negatively Influences the Prognosis
por: Negura, Ion, et al.
Publicado: (2023)

Improvement of Overall Survival Using TKIs as Salvage Therapy in Advanced Thyroid Carcinoma: Real-Life Data on a Single Center Experience
por: Brilli, Lucia, et al.
Publicado: (2021)

Medullary Thyroid Cancer: Updates and Challenges
por: Gild, Matti L, et al.
Publicado: (2023)

Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients
por: Besharat, Z. M., et al.
Publicado: (2023)

Epidemiology of Simultaneous Medullary and Papillary Thyroid Carcinomas (MTC/PTC): An Italian Multicenter Study
por: Appetecchia, Marialuisa, et al.
Publicado: (2019)

Circulating miRNAs in Breast Cancer Diagnosis and Prognosis
por: Cardinali, Barbara, et al.
Publicado: (2022)

Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
por: Gambardella, Claudio, et al.
Publicado: (2019)

Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer
por: Alves dos Santos, Katiusse, et al.
Publicado: (2020)

Clinicopathological characteristics and prognosis of medullary thyroid microcarcinoma: a tumor with a similar prognosis to macrocarcinoma
por: Wu, Xin, et al.
Publicado: (2023)

Medullary thyroid carcinoma: recent advances in identification, treatment, and prognosis
por: Bartz-Kurycki, Marisa A., et al.
Publicado: (2021)

Effect of Pre-Existent Sarcopenia on Oncological Outcome of Advanced Thyroid Cancer Patients Treated with Tyrosine Kinase Inhibitors
por: Dalmiglio, Cristina, et al.
Publicado: (2022)

New Opportunities for Preoperative Diagnosis of Medullary Thyroid Carcinoma
por: Lukyanov, Sergei A., et al.
Publicado: (2023)

The Importance of miRNA in the Diagnosis and Prognosis of Papillary Thyroid Cancer
por: Rogucki, Mariusz, et al.
Publicado: (2021)

The Combination of Sonographic Features and the Seven-Gene Panel May be Useful in the Management of Thyroid Nodules With Indeterminate Cytology
por: Capezzone, Marco, et al.
Publicado: (2021)

Challenges in Using Circulating miRNAs as Cancer Biomarkers
por: Tiberio, Paola, et al.
Publicado: (2015)

Type 2 deiodinase p.Thr92Ala polymorphism does not affect the severity of obesity and weight loss after bariatric surgery
por: Benenati, Nicoletta, et al.
Publicado: (2022)

Thyroid: Medullary Carcinoma
por: Somnay, Yash R., et al.
Publicado: (2013)

Prognosis of radiotherapy in medullary thyroid carcinoma patients without distant metastasis
por: Huang, Shaojun, et al.
Publicado: (2021)

Identification and interaction analysis of key miRNAs in medullary thyroid carcinoma by bioinformatics analysis
por: Zhang, Lijie, et al.
Publicado: (2019)

Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel missense mutation in AVP gene in a large Italian kindred
por: Marzocchi, Carlotta, et al.
Publicado: (2021)

Case Report: A Challenging Clinical Problem of Calcitonin-Negative Medullary Thyroid Cancer Diagnosis and Surveillance
por: Rafaey, Wania, et al.
Publicado: (2022)

Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico
por: Álvarez-Hilario, Lissuly Guadalupe, et al.
Publicado: (2023)

Clinical comments related to medullary thyroid cancer diagnosis and management
por: Duntas, Leonidas H
Publicado: (2013)

Trends in the Diagnosis and Treatment of Patients with Medullary Thyroid Carcinoma in Korea
por: Ahn, Hwa Young, et al.
Publicado: (2020)

Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer
por: de Souza, Marilesia Ferreira, et al.
Publicado: (2017)

Validation of miRNAs as diagnostic and prognostic biomarkers, and possible therapeutic targets in medullary thyroid cancers
por: Mondin, Alberto, et al.
Publicado: (2023)

Medullary carcinoma of the thyroid gland.
por: Russell, C.
Publicado: (1980)

Medullary carcinoma of the thyroid: an update
por: Alevizaki, Maria
Publicado: (2013)

Pediatric Medullary Thyroid Carcinoma
por: Starenki, Dmytro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_02u836svatd9pusqj7pkbghvqi